The $200,000 revenue was primarily from the trial with the US Pharrma company, no actual VX patient revenue, however they have said this will be in the March Quarter but as I have noted they have shown any tendency to update us and my assumption is this will be very slow going for now.
The $200,000 revenue was primarily from the trial with the US...
Add 4DX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
43.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $176.5M | |||
| Open | High | Low | Value | Volume |
| 42.5¢ | 43.0¢ | 41.5¢ | $46.59K | 111.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 87061 | 42.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 43.0¢ | 9979 | 1 |
View Market Depth
| Last trade - 16.10pm 28/08/2024 (20 minute delay) ? |
| 4DX (ASX) Chart |